Provided by Tiger Fintech (Singapore) Pte. Ltd.

Checkpoint Therapeutics, Inc.

4.12
+0.0000
Post-market: 4.120.00000.00%16:05 EDT
Volume:1.26M
Turnover:5.20M
Market Cap:345.11M
PE:-2.91
High:4.14
Open:4.10
Low:4.10
Close:4.12
Loading ...
Dec 09, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Dec 05, 2022

Major Issues Report

8-K - Current report
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2022

Major Issues Report

8-K - Current report
Nov 04, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Major Issues Report

8-K - Current report
Aug 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 21, 2022

Major Issues Report

8-K - Current report
Jun 16, 2022

Major Issues Report

8-K - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 28, 2022

Major Issues Report

8-K - Current report
Jan 25, 2022

Major Issues Report

8-K - Current report
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 11, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities